Intra-Cellular Therapies, Inc. Insider Trading for January 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Intra-Cellular Therapies, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Intra-Cellular Therapies, Inc. for January 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 28 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | J | 23.61 | 3,809 | 89,930 | 4,425 | 8.2 K to 4.4 K (-46.26 %) |
| Jan 28 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Grant | A | 0.00 | 8,043 | 0 | 8,234 | 191 to 8.2 K (+4,210.99 %) |
| Jan 28 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | J | 23.61 | 3,809 | 89,930 | 23,034 | 26.8 K to 23 K (-14.19 %) |
| Jan 28 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Grant | A | 0.00 | 8,043 | 0 | 26,843 | 18.8 K to 26.8 K (+42.78 %) |
| Jan 28 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | J | 23.61 | 9,323 | 220,116 | 1,213,392 | 1.2 M to 1.2 M (-0.76 %) |
| Jan 28 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Grant | A | 0.00 | 18,008 | 0 | 1,222,715 | 1.2 M to 1.2 M (+1.49 %) |
| Jan 16 2020 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Grant | A | 34.31 | 400 | 13,724 | 71,338 | 70.9 K to 71.3 K (+0.56 %) |
| Jan 10 2020 | ITCI | Intra-Cellular The ... | Satlin Andrew | EVP and Chief Medic ... | Option Exercise | M | 0.00 | 22,911 | 0 | 45,824 | |
| Jan 10 2020 | ITCI | Intra-Cellular The ... | Satlin Andrew | EVP and Chief Medic ... | Sell | S | 26.16 | 11,573 | 302,750 | 11,338 | 22.9 K to 11.3 K (-50.51 %) |
| Jan 10 2020 | ITCI | Intra-Cellular The ... | Satlin Andrew | EVP and Chief Medic ... | Buy | M | 0.00 | 22,911 | 0 | 22,911 | 0 to 22.9 K |
| Jan 10 2020 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 20,947 | 0 | 41,896 | |
| Jan 10 2020 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Sell | J | 26.34 | 6,157 | 162,175 | 21,464 | 27.6 K to 21.5 K (-22.29 %) |
| Jan 10 2020 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Buy | M | 0.00 | 20,947 | 0 | 27,621 | 6.7 K to 27.6 K (+313.86 %) |
| Jan 10 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 26.16 | 41,895 | 1,095,973 | 1,204,707 | 1.2 M to 1.2 M (-3.36 %) |
| Jan 10 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 26.16 | 19,638 | 513,730 | 191 | 19.8 K to 191 (-99.04 %) |
| Jan 10 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 26.16 | 19,638 | 513,730 | 18,800 | 38.4 K to 18.8 K (-51.09 %) |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 2.74 | 16,000 | 43,840 | 34,000 | |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 2.74 | 44,000 | 120,560 | 0 | |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 0.00 | 41,895 | 0 | 83,792 | |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 2.74 | 16,000 | 43,840 | 1,246,602 | 1.2 M to 1.2 M (+1.30 %) |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 2.74 | 44,000 | 120,560 | 1,230,602 | 1.2 M to 1.2 M (+3.71 %) |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 0.00 | 41,895 | 0 | 1,186,602 | 1.1 M to 1.2 M (+3.66 %) |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 30.39 | 37,659 | 1,144,457 | 1,144,707 | 1.2 M to 1.1 M (-3.19 %) |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 29.78 | 7,939 | 236,423 | 1,182,366 | 1.2 M to 1.2 M (-0.67 %) |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 2.74 | 16,000 | 43,840 | 34,000 | |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 2.74 | 44,000 | 120,560 | 0 | |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 0.00 | 41,895 | 0 | 83,792 | |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 2.74 | 16,000 | 43,840 | 1,246,602 | 1.2 M to 1.2 M (+1.30 %) |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 2.74 | 44,000 | 120,560 | 1,230,602 | 1.2 M to 1.2 M (+3.71 %) |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Option Exercise | M | 0.00 | 19,638 | 0 | 39,277 | |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 0.00 | 41,895 | 0 | 1,186,602 | 1.1 M to 1.2 M (+3.66 %) |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Buy | M | 0.00 | 19,638 | 0 | 19,829 | 191 to 19.8 K (+10,281.68 %) |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 30.39 | 37,659 | 1,144,457 | 1,144,707 | 1.2 M to 1.1 M (-3.19 %) |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 30.46 | 17,513 | 533,446 | 191 | 17.7 K to 191 (-98.92 %) |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 29.78 | 7,939 | 236,423 | 1,182,366 | 1.2 M to 1.2 M (-0.67 %) |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 29.80 | 3,945 | 117,561 | 17,704 | 21.6 K to 17.7 K (-18.22 %) |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Option Exercise | M | 0.00 | 19,638 | 0 | 39,277 | |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Buy | M | 0.00 | 19,638 | 0 | 38,438 | 18.8 K to 38.4 K (+104.46 %) |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 30.40 | 17,591 | 534,766 | 18,800 | 36.4 K to 18.8 K (-48.34 %) |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 29.80 | 3,867 | 115,237 | 36,391 | 40.3 K to 36.4 K (-9.61 %) |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Option Exercise | M | 0.00 | 19,638 | 0 | 39,277 | |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Buy | M | 0.00 | 19,638 | 0 | 19,829 | 191 to 19.8 K (+10,281.68 %) |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 30.46 | 17,513 | 533,446 | 191 | 17.7 K to 191 (-98.92 %) |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 29.80 | 3,945 | 117,561 | 17,704 | 21.6 K to 17.7 K (-18.22 %) |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Option Exercise | M | 0.00 | 19,638 | 0 | 39,277 | |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Buy | M | 0.00 | 19,638 | 0 | 38,438 | 18.8 K to 38.4 K (+104.46 %) |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 30.40 | 17,591 | 534,766 | 18,800 | 36.4 K to 18.8 K (-48.34 %) |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 29.80 | 3,867 | 115,237 | 36,391 | 40.3 K to 36.4 K (-9.61 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Option Exercise | M | 0.00 | 16,160 | 0 | 16,160 | |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Option Exercise | M | 0.00 | 5,298 | 0 | 0 | |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Buy | M | 0.00 | 16,160 | 0 | 21,649 | 5.5 K to 21.6 K (+294.41 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Buy | M | 0.00 | 5,298 | 0 | 5,489 | 191 to 5.5 K (+2,773.82 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 34.30 | 25 | 858 | 191 | 216 to 191 (-11.57 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 33.23 | 1,200 | 39,876 | 216 | 1.4 K to 216 (-84.75 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 32.43 | 4,959 | 160,820 | 1,416 | 6.4 K to 1.4 K (-77.79 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 31.83 | 1,623 | 51,660 | 6,375 | 8 K to 6.4 K (-20.29 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Grant | A | 0.00 | 7,807 | 0 | 7,998 | 191 to 8 K (+4,087.43 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Option Exercise | M | 0.00 | 16,160 | 0 | 16,160 | |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Option Exercise | M | 0.00 | 5,298 | 0 | 0 | |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Buy | M | 0.00 | 16,160 | 0 | 40,258 | 24.1 K to 40.3 K (+67.06 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Buy | M | 0.00 | 5,298 | 0 | 24,098 | 18.8 K to 24.1 K (+28.18 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Gift | G | 0.00 | 1,000 | 0 | 18,800 | 19.8 K to 18.8 K (-5.05 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 34.30 | 25 | 858 | 19,800 | 19.8 K to 19.8 K (-0.13 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 33.28 | 1,000 | 33,280 | 19,825 | 20.8 K to 19.8 K (-4.80 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 32.46 | 4,982 | 161,716 | 20,825 | 25.8 K to 20.8 K (-19.30 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 31.84 | 1,800 | 57,312 | 25,807 | 27.6 K to 25.8 K (-6.52 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Grant | A | 0.00 | 7,807 | 0 | 27,607 | 19.8 K to 27.6 K (+39.43 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 0.00 | 34,340 | 0 | 34,341 | |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 0.00 | 11,258 | 0 | 0 | |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 2.74 | 6,000 | 16,440 | 44,000 | |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 0.00 | 34,340 | 0 | 1,190,305 | 1.2 M to 1.2 M (+2.97 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 0.00 | 11,258 | 0 | 1,155,965 | 1.1 M to 1.2 M (+0.98 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 34.30 | 56 | 1,921 | 1,144,707 | 1.1 M to 1.1 M (0.00 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 33.25 | 3,000 | 99,750 | 1,144,763 | 1.1 M to 1.1 M (-0.26 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 32.43 | 10,722 | 347,714 | 1,147,763 | 1.2 M to 1.1 M (-0.93 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 31.85 | 3,700 | 117,845 | 1,158,485 | 1.2 M to 1.2 M (-0.32 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 2.74 | 6,000 | 16,440 | 1,162,185 | 1.2 M to 1.2 M (+0.52 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Grant | A | 0.00 | 17,478 | 0 | 1,156,185 | 1.1 M to 1.2 M (+1.53 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | VAN NOSTRAND ROBERT L | Director | Grant | A | 34.31 | 170 | 5,833 | 6,832 | 6.7 K to 6.8 K (+2.55 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 34.31 | 422 | 14,479 | 44,727 | 44.3 K to 44.7 K (+0.95 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 34.31 | 422 | 14,479 | 343,586 | 343.2 K to 343.6 K (+0.12 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Option Exercise | M | 0.00 | 16,160 | 0 | 16,160 | |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Option Exercise | M | 0.00 | 5,298 | 0 | 0 | |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Buy | M | 0.00 | 16,160 | 0 | 21,649 | 5.5 K to 21.6 K (+294.41 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Buy | M | 0.00 | 5,298 | 0 | 5,489 | 191 to 5.5 K (+2,773.82 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 34.30 | 25 | 858 | 191 | 216 to 191 (-11.57 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 33.23 | 1,200 | 39,876 | 216 | 1.4 K to 216 (-84.75 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 32.43 | 4,959 | 160,820 | 1,416 | 6.4 K to 1.4 K (-77.79 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 31.83 | 1,623 | 51,660 | 6,375 | 8 K to 6.4 K (-20.29 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Grant | A | 0.00 | 7,807 | 0 | 7,998 | 191 to 8 K (+4,087.43 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Option Exercise | M | 0.00 | 16,160 | 0 | 16,160 | |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Option Exercise | M | 0.00 | 5,298 | 0 | 0 | |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Buy | M | 0.00 | 16,160 | 0 | 40,258 | 24.1 K to 40.3 K (+67.06 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Buy | M | 0.00 | 5,298 | 0 | 24,098 | 18.8 K to 24.1 K (+28.18 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Gift | G | 0.00 | 1,000 | 0 | 18,800 | 19.8 K to 18.8 K (-5.05 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 34.30 | 25 | 858 | 19,800 | 19.8 K to 19.8 K (-0.13 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 33.28 | 1,000 | 33,280 | 19,825 | 20.8 K to 19.8 K (-4.80 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 32.46 | 4,982 | 161,716 | 20,825 | 25.8 K to 20.8 K (-19.30 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 31.84 | 1,800 | 57,312 | 25,807 | 27.6 K to 25.8 K (-6.52 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Grant | A | 0.00 | 7,807 | 0 | 27,607 | 19.8 K to 27.6 K (+39.43 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 0.00 | 34,340 | 0 | 34,341 | |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 0.00 | 11,258 | 0 | 0 | |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 2.74 | 6,000 | 16,440 | 44,000 | |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 0.00 | 34,340 | 0 | 1,190,305 | 1.2 M to 1.2 M (+2.97 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 0.00 | 11,258 | 0 | 1,155,965 | 1.1 M to 1.2 M (+0.98 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 34.30 | 56 | 1,921 | 1,144,707 | 1.1 M to 1.1 M (0.00 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 33.25 | 3,000 | 99,750 | 1,144,763 | 1.1 M to 1.1 M (-0.26 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 32.43 | 10,722 | 347,714 | 1,147,763 | 1.2 M to 1.1 M (-0.93 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 31.85 | 3,700 | 117,845 | 1,158,485 | 1.2 M to 1.2 M (-0.32 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 2.74 | 6,000 | 16,440 | 1,162,185 | 1.2 M to 1.2 M (+0.52 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Grant | A | 0.00 | 17,478 | 0 | 1,156,185 | 1.1 M to 1.2 M (+1.53 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | VAN NOSTRAND ROBERT L | Director | Grant | A | 34.31 | 170 | 5,833 | 6,832 | 6.7 K to 6.8 K (+2.55 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 34.31 | 422 | 14,479 | 44,727 | 44.3 K to 44.7 K (+0.95 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 34.31 | 422 | 14,479 | 343,586 | 343.2 K to 343.6 K (+0.12 %) |